Akyso Therapeutics

About Akyso Therapeutics

Akyso Therapeutics is a pharmaceutical company focused on developing sustained release drug delivery systems since 2014. Their mission is to address the opioid crisis by providing innovative, long-acting treatment options for opioid use disorder (OUD) and other conditions, improving patient compliance and access to therapy.

Products & Services

iSTEP-N(r):An implantable, subcutaneous, tunable, extended-release polymeric implant containing Naltrexone for treating opioid use disorder. It offers 6-12 months of sustained drug release, is bioabsorbable, and requires no removal.

iSTEP-B:An extended-release buprenorphine implant under development for opioid use disorder treatment.

Specialties

Sustained Release Drug Delivery Subcutaneous Implants Opioid Use Disorder Treatment Bioabsorbable Polymers

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 15000000 MR: - FA: $15 million FAN: 15000000	D: 2025-08-05 FD: 2025-08-05	1 investors

Grant Latest

2025-08-05

$15.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jennifer Sharpe Potter

Professor in the Department of Psychiatry and Vice Dean for Research

S

Steven Cohen

Co-Founder and Co-CEO

J

Jeffrey Benner

Cofounder and Chief Executive Officer

Recent News